Advances in biochemical and biotechnological sciences have transformed modern medical practice, enabling earlier disease detection and more precise therapeutic interventions. The increasing complexity of oncological, infectious, metabolic, and degenerative diseases necessitates diagnostic and therapeutic systems capable of accurately interpreting subtle molecular variations. This review synthesises key innovations in biochemical diagnostics and biotechnology-driven therapeutics, highlighting their clinical relevance and contribution to precision medicine. Recent advancements have significantly improved early disease identification, molecular characterisation, and targeted treatment strategies. These approaches enable minimally invasive monitoring, enhance diagnostic accuracy, and support personalised clinical decision-making across diverse disease conditions. Overall, biochemical and biotechnological innovations are central to advancing precision medicine, and continued validation, optimisation, and integration into healthcare systems will be essential for improving clinical outcomes and sustaining long-term progress.
Kadwe et al. (Tue,) studied this question.